Bristol-Myers Squibb Company and Pfizer Inc. released real-world data (RWD) of outcomes associated with direct oral anticoagulants (DOAC) among non-valvular atrial fibrillation (NVAF) patients during the 2017 American Heart Association (AHA) Scientific Sessions, Nov. 11-15 in Anaheim, Calif. The data was compiled using the U.S. Medicare database – the nation’s largest insurer handling more than 1 billion total claims per year – as well as the Department of Defense (DoD) Military Health System (MHS).

Stratasys Ltd. announced that surgeons at the University of Mainz Cardiothoracic and Vascular Surgery Department in Germany are using Stratasys PolyJet 3-D printing to transform the hospital’s surgical planning process for complex, life-critical vascular cases. According to the University hospital, the use of 3-D printed models for surgical planning has seen a significant reduction in costs at the institution when designing and fitting implants — while the hospital reports relevant time-savings during surgery, leading to an improvement in patient outcomes.

November 15, 2017 — Center for Diagnostic Imaging (CDI), one of the nation’s largest providers of diagnostic imaging ...

Arterys Inc. announced the close of its $30M Series B financing round. The investment was led by Temasek, with strategic investors Northwell Health Ventures, NewYork-Presbyterian, Varian Medical Systems and GE Ventures, and joined by Fosun, DNA Capital, Emergent Medical Partners and ORI Capital. Arterys plans to use the funding to expand its web-based artificial intelligence (AI) platform, and launch several products in oncology and neurology, and to accelerate the commercialization of its cardiac offering. This new round will enable more radiologists to benefit from artificial intelligence in their daily work.